STTK Hisse Senedi Fiyat Grafiği
STTK Kazanmak
Shattuck Labs Inc
$6.85
9.42%
$0.58
Kapanışta: May 08, 16:00:00 GMT-4
$6.72
-1.89%
$-0.12
Sonrası Piyasa: May 08, 20:00:00 GMT-4
Geri
Shattuck Labs Inc (STTK) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$6.26
Açılış fiyatı
$6.37
Günün Aralığı
$6.3 - $6.86
52 haftalık aralık
$0.712 - $8.33
İşlem hacmi
1.5M
Ort.Hacim
611.2K
Dividend yield
--
EPS (TTM)
-0.77
Piyasa Değeri
$507.8M
STTK nedir?
Shattuck Labs, Inc. is a biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. The company is headquartered in Austin, Texas and currently employs 40 full-time employees. The company went IPO on 2020-10-09. The firm is engaged in the development of treatments for inflammatory and immune-mediated diseases. Its lead product candidate, SL-325, is a monoclonal antibody that is designed to bind to death receptor 3 (DR3) and inhibit its interaction with its ligand, TL1A. TL1A is a costimulatory ligand in the tumor necrosis factor superfamily, which activates immune responses through binding a single receptor, DR3. The firm is conducting a Phase I clinical trial in healthy volunteers. In addition, the Company is also developing SL-425, a half-life extended version of SL-325. The company is also developing multiple preclinical DR3-based bispecific antibodies, which are designed to inhibit both the DR3/TL1A axis and another biologically relevant target for the treatment of patients with inflammatory bowel disease.
